— Know what they know.
Not Investment Advice
Also trades as: PFE.DE (XETRA) · $vol 1M · PFE.NE (NEO) · $vol 1M · PFE.F (FSX) · $vol 0M · PFE.BA (BUE) · $vol 0M

PFE NYSE

Pfizer Inc.
1W: +0.8% 1M: -3.2% 3M: -2.6% YTD: +4.8% 1Y: +14.2% 3Y: -18.3% 5Y: -19.0%
$25.90
-0.05 (-0.19%)
 
Weekly Expected Move ±2.4%
$24 $25 $25 $26 $27
NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Neutral · Power 51 · $147.6B mcap · 5.69B float · 0.665% daily turnover · Short 39% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 10.1%  ·  5Y Avg: 12.9%
Cost Advantage
60
Intangibles
52
Switching Cost
34
Network Effect
45
Scale ★
90
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PFE shows a Weak competitive edge (53.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 10.1% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$26
Low
$26
Avg Target
$26
High
Based on 1 analyst since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 16Hold: 21Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$27.00
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-14 Wolfe Research Alexandria Hammond $24 $26 +2 +0.2% $25.96
2026-03-17 Morgan Stanley Terence Flynn $28 $27 -1 -0.2% $27.05
2026-03-09 BMO Capital Evan David Seigerman $36 $30 -6 +13.3% $26.48
2026-02-24 RBC Capital Trung Huynh $44 $25 -19 -7.9% $27.14
2026-02-19 Barclays Emily Field $32 $25 -7 -6.9% $26.86
2026-02-12 Daiwa Narumi Nakagiri $34 $27 -7 -2.6% $27.73
2026-01-27 Cantor Fitzgerald $24 $27 +3 +4.3% $25.88
2026-01-06 UBS $28 $25 -3 -1.7% $25.43
2025-12-17 Wolfe Research Alexandria Hammond $46 $24 -22 -6.0% $25.53
2025-12-12 Morgan Stanley $32 $28 -4 +8.1% $25.89
2025-12-10 HSBC Rajesh Kumar Initiated $29 +14.5% $25.33
2025-11-24 Guggenheim $36 $35 -1 +39.1% $25.17
2025-11-05 Goldman Sachs Asad Haider $33 $26 -7 +7.3% $24.23
2025-10-31 Bernstein Courtney Breen $32 $30 -2 +22.7% $24.45
2025-10-10 Morgan Stanley $20 $32 +12 +26.8% $25.24
2025-10-01 UBS Tim Anderson $60 $28 -32 +3.1% $27.16
2025-04-22 Cantor Fitzgerald Carter Gould $75 $24 -51 +6.5% $22.53
2024-12-18 Truist Financial Robyn Karnauskas Initiated $32 +23.6% $25.89
2024-10-30 Goldman Sachs Chris Shibutani $34 $33 -1 +16.0% $28.46
2024-10-17 Bernstein Courtney Breen $65 $32 -33 +7.9% $29.67
2024-09-25 Barclays Carter Gould $30 $32 +2 +10.6% $28.93
2024-08-07 Daiwa Narumi Nakagiri Initiated $34 +17.9% $28.85
2024-07-31 Wells Fargo Mohit Bansal $141 $30 -111 -4.4% $31.39
2024-07-31 Goldman Sachs Chris Shibutani $60 $34 -26 +8.3% $31.39
2024-07-29 Guggenheim Vamil Divan Initiated $36 +17.2% $30.72
2024-07-10 Barclays Carter Gould $44 $30 -14 +8.2% $27.72
2024-05-22 BMO Capital Evan Seigerman $76 $36 -40 +21.6% $29.60
2023-12-14 Morgan Stanley Thomas Yeh $45 $20 -25 -25.7% $26.93
2023-02-01 Morgan Stanley $53 $45 -8 +2.7% $43.84
2023-02-01 Credit Suisse $55 $50 -5 +14.7% $43.59
2023-02-01 Barclays $54 $44 -10 -0.4% $44.16
2023-02-01 Atlantic Equities Initiated $46 +4.2% $44.16
2023-02-01 Leerink Partners $55 $48 -7 +8.7% $44.16
2022-12-14 Morgan Stanley $52 $53 +1 -3.2% $54.73
2022-12-13 Goldman Sachs Chris Shibutani $50 $60 +10 +12.4% $53.37
2022-11-17 Credit Suisse Initiated $55 +13.8% $48.33
2022-05-23 Leerink Partners David Risinger $56 $55 -1 +4.0% $52.88
2022-05-10 Wells Fargo Mohit Bansal $55 $141 +86 +639.9% $19.11
2022-05-08 Wells Fargo Mohit Bansal Initiated $55 +12.2% $49.04
2022-05-04 Morgan Stanley $55 $52 -3 +4.7% $49.68
2022-05-01 Mizuho Securities Vamil Divan Initiated $55 +12.1% $49.07
2022-04-15 Cantor Fitzgerald Louise Chen Initiated $75 +41.2% $53.12
2022-04-09 Morgan Stanley Terrance Flynn Initiated $55 -0.3% $55.17
2022-04-08 Citigroup Andrew Baum Initiated $57 +3.3% $55.17
2022-03-11 Bank of America Securities Geoff Meacham Initiated $70 +39.2% $50.27
2022-02-07 Goldman Sachs Chris Shibutani Initiated $50 -3.3% $51.70
2022-02-07 J.P. Morgan Chris Schott Initiated $57 +10.3% $51.70
2022-02-07 Barclays Carter Gould Initiated $54 +4.4% $51.70
2022-01-14 BMO Capital Evan Seigerman Initiated $76 +38.3% $54.95
2022-01-02 Bernstein Aaron Gal Initiated $65 +15.6% $56.22

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
4
ROE
4
ROA
4
D/E
1
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PFE receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (4/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (2/5).
Rating Change History
DateFromTo
2026-04-24 A- B+
2026-04-01 B+ A-
2026-02-26 B B+
2026-02-23 B- B
2026-02-04 A- B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

52 Grade A
Profitability
62
Balance Sheet
47
Earnings Quality
77
Growth
36
Value
56
Momentum
68
Safety
50
Cash Flow
55
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PFE scores highest in Earnings Quality (77/100) and lowest in Growth (36/100). An overall grade of A places PFE among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.05
Grey Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.71
Unlikely Manipulator
Ohlson O-Score
-8.64
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB+
Score: 48.0/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.60x
Accruals: -2.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PFE scores 2.05, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PFE scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PFE's score of -2.71 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PFE's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PFE receives an estimated rating of BB+ (score: 48.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PFE's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
19.68x
PEG
-3.42x
P/S
2.33x
P/B
1.64x
P/FCF
16.34x
P/OCF
12.93x
EV/EBITDA
12.32x
EV/Revenue
3.30x
EV/EBIT
19.36x
EV/FCF
22.01x
Earnings Yield
4.83%
FCF Yield
6.12%
Shareholder Yield
6.31%
Graham Number
$21.07
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 19.7x earnings, PFE trades at a reasonable valuation. Graham's intrinsic value formula yields $21.07 per share, 23% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.948
NI / EBT
×
Interest Burden
0.733
EBT / EBIT
×
EBIT Margin
0.170
EBIT / Rev
×
Asset Turnover
0.300
Rev / Assets
×
Equity Multiplier
2.413
Assets / Equity
=
ROE
8.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PFE's ROE of 8.6% is driven by Asset Turnover (0.300), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.95 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$11.11
Price/Value
2.43x
Margin of Safety
-143.38%
Premium
143.38%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PFE's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. PFE trades at a 143% premium to its adjusted intrinsic value of $11.11, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 19.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$25.90
Median 1Y
$24.63
5th Pctile
$15.72
95th Pctile
$38.61
Ann. Volatility
26.1%
Analyst Target
$27.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
A. Bourla
Chairman and Chief Executive Officer
$1,800,000 $9,442,705 $27,585,301
C. Boshoff Scientific
ntific Officer and President, Research & Development
$1,400,000 $1,808,655 $10,006,039
D. Denton Financial
ancial Officer, EVP
$1,388,964 $2,367,893 $9,670,182
A. Malik U.S.
f U.S. Commercial Officer, EVP
$1,386,817 $2,281,630 $9,429,227
D. Lankler Legal
Legal Officer, EVP
$1,411,787 $1,976,390 $9,106,276

CEO Pay Ratio

155:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $27,585,301
Avg Employee Cost (SGA/emp): $177,947
Employees: 75,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
75,000
-7.4% YoY
Revenue / Employee
$834,387
Rev: $62,579,000,000
Profit / Employee
$103,600
NI: $7,770,000,000
SGA / Employee
$177,947
Avg labor cost proxy
R&D / Employee
$159,680
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 20.6% 31.1% 31.7% 35.9% 41.7% 42.4% 36.3% 33.6% 24.9% 12.1% 2.3% -0.3% -2.8% 4.6% 9.1% 8.9% 12.1% 11.1% 8.9% 8.6% 8.58%
ROA 8.1% 12.2% 13.2% 15.0% 17.5% 17.7% 16.6% 15.3% 11.4% 5.5% 1.0% -0.1% -1.2% 2.0% 3.6% 3.6% 4.9% 4.5% 3.7% 3.6% 3.55%
ROIC 14.2% 20.2% 24.3% 29.9% 37.5% 38.9% 31.9% 29.3% 21.1% 10.6% 6.6% 1.4% 1.2% 7.6% 12.8% 13.6% 14.3% 13.9% 11.4% 10.1% 10.07%
ROCE 11.8% 17.4% 18.4% 20.9% 24.1% 24.9% 23.2% 21.4% 15.6% 7.9% 1.8% 0.5% -0.7% 3.9% 8.1% 7.6% 9.4% 8.5% 6.0% 6.3% 6.30%
Gross Margin 58.5% 54.8% 55.2% 57.9% 67.3% 69.1% 55.1% 67.8% 64.7% 21.4% 41.0% 70.6% 62.1% 60.8% 73.0% 71.7% 64.3% 74.9% 70.0% 67.3% 67.26%
Operating Margin 31.7% 32.2% 13.8% 39.1% 46.7% 42.8% 22.0% 36.2% 18.1% -22.3% -8.7% 30.6% 14.1% 28.1% 32.2% 33.7% 24.4% 21.3% 21.0% 27.9% 27.90%
Net Margin 30.7% 33.9% 14.2% 30.7% 35.6% 38.1% 20.6% 30.0% 17.9% -17.7% -22.9% 21.0% 0.2% 25.3% 2.3% 21.6% 19.9% 21.3% -9.4% 18.6% 18.60%
EBITDA Margin 45.4% 39.6% 22.7% 41.2% 46.6% 46.4% 29.1% 43.7% 33.5% -8.1% -12.1% 40.0% 18.1% 41.0% 29.0% 36.9% 36.3% 33.9% 4.3% 36.1% 36.09%
FCF Margin 37.3% 42.4% 36.7% 34.4% 28.1% 23.4% 25.9% 21.7% 13.6% 11.8% 8.0% 9.1% 8.6% 13.6% 15.5% 18.0% 19.5% 16.5% 14.5% 15.0% 14.98%
OCF Margin 42.6% 46.7% 40.1% 37.4% 31.1% 26.6% 29.2% 25.7% 18.6% 17.4% 14.6% 15.3% 14.2% 18.6% 20.0% 22.4% 23.8% 20.8% 18.7% 18.9% 18.93%
ROE 3Y Avg snapshot only 5.75%
ROE 5Y Avg snapshot only 16.06%
ROA 3Y Avg snapshot only 2.39%
ROIC 3Y Avg snapshot only 5.04%
ROIC Economic snapshot only 9.25%
Cash ROA snapshot only 5.76%
Cash ROIC snapshot only 8.54%
CROIC snapshot only 6.76%
NOPAT Margin snapshot only 22.31%
Pretax Margin snapshot only 12.49%
R&D / Revenue snapshot only 19.62%
SGA / Revenue snapshot only 20.98%
SBC / Revenue snapshot only 1.07%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 13.89 10.08 12.48 9.66 8.44 7.01 7.89 6.83 8.36 15.51 66.95 -489.78 -55.66 35.67 17.59 17.35 12.40 13.59 18.22 20.69 19.677
P/S Ratio 3.26 2.87 3.41 2.64 2.44 2.09 2.47 2.13 2.29 2.34 2.40 2.52 2.57 2.52 2.22 2.18 2.09 2.13 2.26 2.45 2.331
P/B Ratio 2.85 3.14 3.59 3.16 3.20 2.70 2.59 2.07 1.88 1.70 1.61 1.58 1.62 1.71 1.60 1.55 1.51 1.51 1.64 1.79 1.636
P/FCF 8.74 6.78 9.29 7.67 8.69 8.93 9.51 9.81 16.86 19.86 29.81 27.63 30.01 18.53 14.35 12.16 10.72 12.86 15.60 16.34 16.340
P/OCF 7.66 6.15 8.52 7.05 7.86 7.84 8.46 8.28 12.35 13.49 16.42 16.45 18.03 13.53 11.07 9.76 8.78 10.20 12.10 12.93 12.930
EV/EBITDA 10.36 8.22 9.22 7.33 6.59 5.45 6.33 5.46 6.40 9.49 21.03 26.80 36.91 15.22 9.04 9.22 7.90 8.50 11.64 12.32 12.324
EV/Revenue 3.73 3.25 3.49 2.70 2.50 2.15 2.59 2.26 2.45 2.52 3.38 3.56 3.60 3.48 2.95 2.93 2.82 2.87 3.12 3.30 3.298
EV/EBIT 13.67 10.04 11.07 8.63 7.58 6.21 7.22 6.34 7.92 14.24 61.48 223.08 -167.21 30.33 13.66 14.12 11.25 12.43 19.17 19.36 19.359
EV/FCF 10.01 7.66 9.49 7.86 8.90 9.18 9.97 10.41 17.99 21.35 41.94 39.02 42.10 25.60 19.08 16.31 14.46 17.34 21.53 22.01 22.015
Earnings Yield 7.2% 9.9% 8.0% 10.3% 11.8% 14.3% 12.7% 14.6% 12.0% 6.4% 1.5% -0.2% -1.8% 2.8% 5.7% 5.8% 8.1% 7.4% 5.5% 4.8% 4.83%
FCF Yield 11.4% 14.8% 10.8% 13.0% 11.5% 11.2% 10.5% 10.2% 5.9% 5.0% 3.4% 3.6% 3.3% 5.4% 7.0% 8.2% 9.3% 7.8% 6.4% 6.1% 6.12%
EV/OCF snapshot only 17.421
EV/Gross Profit snapshot only 4.755
Acquirers Multiple snapshot only 14.064
Shareholder Yield snapshot only 6.31%
Graham Number snapshot only $21.07
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.35 1.35 1.40 1.40 1.40 1.40 1.22 1.22 1.22 1.22 0.91 0.91 0.91 0.91 1.17 1.17 1.17 1.17 1.16 1.16 1.160
Quick Ratio 1.04 1.04 1.19 1.19 1.19 1.19 1.00 1.00 1.00 1.00 0.69 0.69 0.69 0.69 0.92 0.92 0.92 0.92 0.87 0.87 0.872
Debt/Equity 0.61 0.61 0.48 0.48 0.48 0.48 0.36 0.36 0.36 0.36 0.80 0.80 0.80 0.80 0.76 0.76 0.76 0.76 0.78 0.78 0.780
Net Debt/Equity 0.41 0.41 0.08 0.08 0.08 0.08 0.13 0.13 0.13 0.13 0.65 0.65 0.65 0.65 0.53 0.53 0.53 0.53 0.62 0.62 0.622
Debt/Assets 0.25 0.25 0.20 0.20 0.20 0.20 0.18 0.18 0.18 0.18 0.31 0.31 0.31 0.31 0.31 0.31 0.31 0.31 0.32 0.32 0.324
Debt/EBITDA 1.92 1.40 1.20 1.09 0.96 0.94 0.85 0.90 1.16 1.90 7.41 9.53 12.91 5.12 3.23 3.37 2.94 3.16 4.02 3.98 3.979
Net Debt/EBITDA 1.31 0.95 0.19 0.17 0.15 0.15 0.30 0.31 0.40 0.66 6.08 7.82 10.60 4.20 2.24 2.34 2.04 2.20 3.21 3.18 3.177
Interest Coverage 11.24 16.89 19.82 22.65 26.63 27.85 29.03 26.87 16.71 6.68 1.48 0.33 -0.41 2.28 4.45 4.39 5.65 5.36 3.82 4.02 4.017
Equity Multiplier 2.44 2.44 2.35 2.35 2.35 2.35 2.06 2.06 2.06 2.06 2.54 2.54 2.54 2.54 2.42 2.42 2.42 2.42 2.41 2.41 2.407
Cash Ratio snapshot only 0.368
Debt Service Coverage snapshot only 6.310
Cash to Debt snapshot only 0.202
FCF to Debt snapshot only 0.141
Defensive Interval snapshot only 319.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.34 0.43 0.48 0.55 0.60 0.60 0.53 0.49 0.41 0.37 0.28 0.26 0.27 0.29 0.29 0.28 0.29 0.29 0.30 0.30 0.300
Inventory Turnover 2.57 3.62 4.02 4.70 4.84 4.39 4.19 3.65 3.15 3.55 3.10 2.94 2.99 2.60 2.01 1.96 1.98 1.72 1.73 1.80 1.805
Receivables Turnover 7.54 9.41 8.38 9.53 10.45 10.30 8.95 8.31 6.99 6.18 5.29 4.97 4.99 5.37 5.53 5.42 5.54 5.45 5.36 5.43 5.426
Payables Turnover 4.75 6.70 6.97 8.15 8.40 7.61 6.10 5.31 4.59 5.17 4.40 4.17 4.23 3.69 3.43 3.35 3.38 2.93 3.41 3.57 3.570
DSO 48 39 44 38 35 35 41 44 52 59 69 73 73 68 66 67 66 67 68 67 67.3 days
DIO 142 101 91 78 75 83 87 100 116 103 118 124 122 140 182 186 184 212 211 202 202.2 days
DPO 77 54 52 45 43 48 60 69 80 71 83 88 86 99 107 109 108 125 107 102 102.2 days
Cash Conversion Cycle 114 85 82 71 67 71 68 75 88 91 104 110 109 109 141 144 142 155 173 167 167.2 days
Fixed Asset Turnover snapshot only 2.941
Operating Cycle snapshot only 269.5 days
Cash Velocity snapshot only 4.657
Capital Intensity snapshot only 3.288
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 22.1% 61.0% 94.2% 99.7% 83.1% 44.6% 23.4% 0.8% -22.6% -30.6% -40.6% -39.9% -28.3% -12.8% 6.8% 11.6% 13.5% 3.9% -1.6% 1.4% 1.36%
Net Income -8.4% 1.5% 1.4% 1.4% 1.3% 51.2% 41.1% 15.1% -26.6% -64.8% -93.2% -1.0% -1.1% -59.2% 2.8% 28.3% 5.1% 1.3% -3.1% -4.8% -4.78%
EPS -9.4% 1.4% 1.4% 1.3% 1.2% 51.4% 41.7% 15.7% -26.6% -64.4% -93.1% -1.0% -1.1% -59.6% 2.7% 28.3% 5.1% 1.3% -2.8% -5.1% -5.13%
FCF 63.8% 1.8% 1.6% 1.5% 37.8% -20.2% -12.9% -36.4% -62.5% -65.0% -81.6% -74.7% -54.9% 0.6% 1.1% 1.2% 1.6% 26.1% -7.7% -15.5% -15.47%
EBITDA -9.3% 1.4% 1.3% 1.1% 92.6% 44.1% 33.5% 13.2% -21.9% -53.3% -76.7% -80.7% -81.7% -24.8% 1.2% 1.7% 3.2% 53.0% -19.1% -14.7% -14.68%
Op. Income 28.9% 91.7% 1.4% 1.5% 1.4% 84.7% 74.2% 28.2% -29.2% -68.4% -87.5% -92.4% -91.0% -10.9% 2.6% 5.5% 7.7% 72.3% -9.9% -13.7% -13.67%
OCF Growth snapshot only -14.33%
Asset Growth snapshot only -2.45%
Equity Growth snapshot only -1.96%
Debt Growth snapshot only 0.63%
Shares Change snapshot only 0.37%
Dividend Growth snapshot only 2.11%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.3% 9.0% 14.9% 19.7% 23.6% 23.5% 24.7% 24.1% 20.1% 17.3% 12.5% 6.5% 0.5% -4.4% -7.8% -12.2% -14.3% -14.3% -14.6% -12.1% -12.08%
Revenue 5Y 1.1% 5.3% 9.0% 11.9% 14.1% 13.7% 13.8% 12.1% 8.1% 5.4% 2.1% 0.8% 0.9% 2.6% 4.2% 5.1% 7.1% 7.9% 8.4% 6.5% 6.46%
EPS 3Y -15.5% -4.8% 26.0% 30.0% 32.0% 22.0% 23.6% 21.8% 14.2% 9.4% -38.4% -39.8% -28.5% -32.0% -28.4% -30.9% -37.0% -36.4% -36.35%
EPS 5Y 14.8% 27.6% 27.0% 29.7% 30.2% 26.2% 9.2% 7.1% -0.1% -14.2% -27.8% -23.6% -13.4% -13.3% -5.7% 4.0% -3.3% -7.1% -7.08%
Net Income 3Y -16.8% -6.2% 25.8% 30.0% 32.3% 22.4% 24.5% 22.6% 14.9% 9.5% -38.5% -39.9% -28.8% -32.2% -28.4% -30.9% -37.2% -36.3% -36.34%
Net Income 5Y 13.0% 25.9% 25.4% 28.3% 28.7% 24.9% 8.0% 6.0% -1.0% -15.2% -28.2% -23.4% -13.2% -13.0% -5.4% 4.2% -3.2% -6.9% -6.85%
EBITDA 3Y -1.3% 8.5% 16.2% 19.8% 25.4% 14.8% 17.5% 18.0% 10.9% 17.3% -10.0% -22.5% -35.0% -20.3% -12.3% -16.5% -16.0% -18.7% -25.8% -24.0% -23.97%
EBITDA 5Y 2.3% 11.4% 15.0% 16.6% 17.1% 15.0% 15.6% 14.0% 7.6% -3.0% -13.4% -17.8% -22.4% -11.9% -3.9% -3.3% 0.7% 13.2% 5.0% 1.2% 1.20%
Gross Profit 3Y -1.0% 3.8% 7.6% 11.2% 16.3% 18.3% 19.1% 20.1% 15.5% 6.3% -0.0% -4.7% -8.4% -5.2% -3.3% -7.2% -10.5% -10.5% -11.1% -10.0% -10.01%
Gross Profit 5Y -2.4% 0.9% 3.9% 6.8% 10.3% 11.1% 11.2% 10.4% 6.2% -0.0% -4.5% -6.1% -6.2% -1.2% 2.8% 3.7% 5.8% 7.6% 8.1% 6.5% 6.49%
Op. Income 3Y -0.6% 10.3% 12.7% 19.9% 29.0% 32.9% 39.2% 39.7% 29.7% 3.8% -19.2% -37.4% -46.6% -19.5% -7.8% -14.0% -17.8% -21.4% -26.0% -24.6% -24.63%
Op. Income 5Y 0.3% 7.2% 9.2% 13.8% 19.0% 20.0% 21.5% 19.4% 10.7% -4.7% -20.8% -30.0% -32.8% -7.9% 3.9% 6.2% 11.4% 11.5% 11.3% 6.7% 6.68%
FCF 3Y 10.6% 23.2% 29.9% 34.3% 34.3% 29.0% 37.6% 20.5% -5.4% -7.4% -25.5% -26.7% -38.5% -34.5% -30.9% -29.3% -24.1% -23.7% -29.6% -22.3% -22.29%
FCF 5Y 9.4% 18.1% 16.5% 18.2% 16.1% 11.6% 12.8% 6.7% -6.9% -12.2% -18.9% -17.2% -16.4% -5.5% -0.3% -0.6% -0.3% 0.1% -4.8% -6.1% -6.05%
OCF 3Y 10.5% 21.9% 27.2% 30.6% 30.0% 25.2% 32.5% 19.5% -0.9% -1.4% -15.5% -18.4% -30.2% -29.6% -26.9% -26.0% -21.5% -21.1% -26.3% -20.6% -20.59%
OCF 5Y 9.5% 17.1% 15.4% 16.9% 15.2% 11.1% 12.2% 7.3% -3.6% -7.6% -11.3% -11.2% -11.0% -3.6% 0.2% -0.0% 0.3% 0.8% -4.1% -5.4% -5.39%
Assets 3Y -3.5% -3.5% 4.4% 4.4% 4.4% 4.4% 5.6% 5.6% 5.6% 5.6% 13.7% 13.7% 13.7% 13.7% 5.5% 5.5% 5.5% 5.5% 1.8% 1.8% 1.82%
Assets 5Y -1.6% -1.6% 1.1% 1.1% 1.1% 1.1% 2.8% 2.8% 2.8% 2.8% 7.3% 7.3% 7.3% 7.3% 5.0% 5.0% 5.0% 5.0% 6.2% 6.2% 6.18%
Equity 3Y -3.9% -3.9% 6.8% 6.8% 6.8% 6.8% 14.9% 14.9% 14.9% 14.9% 12.1% 12.1% 12.1% 12.1% 4.5% 4.5% 4.5% 4.5% -3.3% -3.3% -3.31%
Book Value 3Y -2.4% -2.5% 6.9% 6.7% 6.5% 6.4% 14.1% 14.1% 14.2% 14.8% 12.2% 11.8% 12.0% 12.2% 4.9% 4.8% 4.6% 4.6% -3.0% -3.3% -3.33%
Dividend 3Y 3.1% 2.8% 1.2% 1.1% 0.9% 0.6% 0.3% 0.2% 0.3% 0.8% 1.1% 0.8% 0.9% 1.1% 1.3% 1.2% 1.0% 0.9% 1.2% 0.7% 0.67%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.01 0.10 0.18 0.29 0.39 0.50 0.54 0.57 0.46 0.38 0.22 0.14 0.07 0.06 0.02 0.01 0.01 0.02 0.03 0.02 0.025
Earnings Stability 0.13 0.17 0.14 0.22 0.29 0.26 0.25 0.27 0.12 0.01 0.00 0.00 0.04 0.06 0.07 0.11 0.13 0.10 0.15 0.21 0.210
Margin Stability 0.94 0.92 0.91 0.91 0.92 0.92 0.91 0.91 0.92 0.88 0.86 0.86 0.87 0.90 0.87 0.86 0.86 0.87 0.87 0.87 0.871
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.97 0.50 0.50 0.50 0.50 0.50 0.84 0.94 0.89 0.50 0.50 0.20 0.20 0.50 0.50 0.20 0.20 0.50 0.99 0.50 0.500
Earnings Smoothness 0.91 0.15 0.17 0.19 0.23 0.59 0.66 0.86 0.69 0.04 0.00 0.16 0.00 0.21 0.97 0.95 0.951
ROE Trend -0.01 0.12 0.09 0.12 0.16 0.17 0.11 0.06 -0.07 -0.24 -0.28 -0.32 -0.33 -0.20 -0.09 -0.06 0.02 0.03 0.03 0.04 0.044
Gross Margin Trend -0.06 -0.11 -0.14 -0.14 -0.09 -0.04 -0.02 0.02 0.02 -0.08 -0.10 -0.11 -0.12 0.01 0.11 0.10 0.11 0.15 0.12 0.11 0.111
FCF Margin Trend 0.12 0.20 0.13 0.09 -0.04 -0.10 -0.06 -0.09 -0.19 -0.21 -0.23 -0.19 -0.12 -0.04 -0.02 0.03 0.08 0.04 0.03 0.01 0.014
Sustainable Growth Rate 7.0% 17.5% 19.2% 23.4% 29.1% 29.7% 25.9% 23.1% 14.3% 1.5% -7.7% -5.6% -1.7% -1.9% 1.3% 0.1% -2.3% -2.6% -2.62%
Internal Growth Rate 2.8% 7.4% 8.7% 10.8% 13.9% 14.2% 13.4% 11.8% 7.0% 0.7% 0.5% 0.1%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.81 1.64 1.47 1.37 1.07 0.89 0.93 0.82 0.68 1.15 4.08 -29.78 -3.09 2.64 1.59 1.78 1.41 1.33 1.51 1.60 1.600
FCF/OCF 0.88 0.91 0.92 0.92 0.90 0.88 0.89 0.84 0.73 0.68 0.55 0.60 0.60 0.73 0.77 0.80 0.82 0.79 0.78 0.79 0.791
FCF/Net Income snapshot only 1.266
OCF/EBITDA snapshot only 0.707
CapEx/Revenue 5.3% 4.3% 3.3% 3.0% 3.0% 3.2% 3.2% 4.0% 5.0% 5.6% 6.6% 6.2% 5.7% 5.0% 4.6% 4.4% 4.3% 4.3% 4.2% 4.0% 3.95%
CapEx/Depreciation snapshot only 0.406
Accruals Ratio -0.07 -0.08 -0.06 -0.06 -0.01 0.02 0.01 0.03 0.04 -0.01 -0.03 -0.04 -0.05 -0.03 -0.02 -0.03 -0.02 -0.01 -0.02 -0.02 -0.021
Sloan Accruals snapshot only -0.036
Cash Flow Adequacy snapshot only 0.976
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 4.8% 4.4% 3.1% 3.6% 3.6% 4.3% 3.6% 4.6% 5.1% 5.6% 6.5% 6.6% 6.5% 6.2% 6.7% 7.0% 7.2% 7.3% 6.9% 6.3% 6.64%
Dividend/Share $1.51 $1.51 $1.51 $1.53 $1.55 $1.56 $1.56 $1.58 $1.59 $1.63 $1.64 $1.64 $1.65 $1.66 $1.67 $1.68 $1.69 $1.70 $1.72 $1.71 $1.72
Payout Ratio 66.0% 44.0% 39.3% 34.9% 30.3% 30.0% 28.6% 31.1% 42.4% 87.7% 4.3% 2.2% 1.2% 1.2% 89.7% 98.8% 1.3% 1.3% 1.31%
FCF Payout Ratio 41.6% 29.5% 29.2% 27.7% 31.2% 38.2% 34.5% 44.7% 85.4% 1.1% 1.9% 1.8% 2.0% 1.1% 96.7% 85.4% 77.5% 93.5% 1.1% 1.0% 1.03%
Total Payout Ratio 66.0% 44.0% 39.3% 42.8% 37.1% 36.7% 35.0% 31.1% 42.4% 87.7% 4.3% 2.2% 1.2% 1.2% 89.7% 98.8% 1.3% 1.3% 1.31%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.09 0.08 0.07 0.07 0.07 0.07 0.07 0.07 0.08 0.08 0.09 0.10 0.09 0.09 0.10 0.10 0.10 0.10 0.10 0.08 0.084
Buyback Yield 0.0% 0.0% 0.0% 0.8% 0.8% 1.0% 0.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.8% 0.8% 1.0% 0.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 4.8% 4.4% 3.1% 4.4% 4.4% 5.2% 4.4% 4.6% 5.1% 5.6% 6.5% 6.6% 6.5% 6.2% 6.7% 7.0% 7.2% 7.3% 6.9% 6.3% 6.31%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.94 0.94 0.91 0.91 0.91 0.89 0.90 0.91 0.94 1.00 2.02 0.16 0.62 1.09 1.00 1.07 1.02 1.07 1.03 0.95 0.948
Interest Burden (EBT/EBIT) 0.91 0.94 0.95 0.96 0.96 0.96 0.97 0.96 0.94 0.85 0.32 -2.01 3.44 0.56 0.58 0.57 0.66 0.63 0.74 0.73 0.733
EBIT Margin 0.27 0.32 0.31 0.31 0.33 0.35 0.36 0.36 0.31 0.18 0.05 0.02 -0.02 0.11 0.22 0.21 0.25 0.23 0.16 0.17 0.170
Asset Turnover 0.34 0.43 0.48 0.55 0.60 0.60 0.53 0.49 0.41 0.37 0.28 0.26 0.27 0.29 0.29 0.28 0.29 0.29 0.30 0.30 0.300
Equity Multiplier 2.55 2.55 2.39 2.39 2.39 2.39 2.19 2.19 2.19 2.19 2.29 2.29 2.29 2.29 2.48 2.48 2.48 2.48 2.41 2.41 2.413
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $2.29 $3.44 $3.85 $4.38 $5.13 $5.21 $5.46 $5.07 $3.76 $1.85 $0.38 $-0.05 $-0.46 $0.75 $1.41 $1.38 $1.88 $1.72 $1.37 $1.31 $1.31
Book Value/Share $11.14 $11.05 $13.38 $13.41 $13.52 $13.50 $16.66 $16.70 $16.74 $16.94 $15.76 $15.62 $15.63 $15.60 $15.47 $15.45 $15.46 $15.44 $15.21 $15.09 $15.89
Tangible Book/Share $-2.58 $-2.56 $0.49 $0.49 $0.50 $0.50 $0.16 $0.16 $0.16 $0.16 $-7.73 $-7.67 $-7.67 $-7.65 $-6.27 $-6.26 $-6.26 $-6.25 $-6.77 $-6.72 $-6.72
Revenue/Share $9.74 $12.07 $14.09 $16.05 $17.73 $17.47 $17.47 $16.27 $13.73 $12.27 $10.55 $9.82 $9.87 $10.59 $11.16 $10.94 $11.19 $10.99 $11.01 $11.05 $11.13
FCF/Share $3.64 $5.12 $5.18 $5.52 $4.98 $4.09 $4.53 $3.53 $1.87 $1.45 $0.85 $0.90 $0.84 $1.44 $1.72 $1.96 $2.18 $1.82 $1.60 $1.65 $1.67
OCF/Share $4.15 $5.64 $5.65 $6.01 $5.51 $4.65 $5.10 $4.18 $2.55 $2.13 $1.54 $1.51 $1.41 $1.97 $2.23 $2.45 $2.66 $2.29 $2.06 $2.09 $2.11
Cash/Share $2.15 $2.14 $5.39 $5.40 $5.44 $5.43 $3.96 $3.97 $3.98 $4.03 $2.25 $2.23 $2.23 $2.22 $3.59 $3.59 $3.59 $3.58 $2.39 $2.37 $2.30
EBITDA/Share $3.51 $4.77 $5.33 $5.92 $6.72 $6.89 $7.14 $6.73 $5.25 $3.26 $1.69 $1.30 $0.96 $2.43 $3.64 $3.48 $3.99 $3.70 $2.95 $2.96 $2.96
Debt/Share $6.74 $6.69 $6.41 $6.43 $6.48 $6.47 $6.07 $6.09 $6.10 $6.17 $12.55 $12.44 $12.44 $12.42 $11.75 $11.73 $11.74 $11.72 $11.86 $11.76 $11.76
Net Debt/Share $4.59 $4.55 $1.03 $1.03 $1.04 $1.04 $2.11 $2.12 $2.12 $2.15 $10.30 $10.21 $10.21 $10.19 $8.16 $8.15 $8.15 $8.14 $9.47 $9.39 $9.39
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.046
Altman Z-Prime snapshot only 3.670
Piotroski F-Score 5 6 7 7 8 8 6 6 3 5 5 5 4 5 7 7 7 7 4 4 4
Beneish M-Score -2.19 -1.92 -1.90 -2.08 -2.18 -2.15 -2.44 -2.50 -2.06 -1.24 -2.10 -2.52 -2.54 -2.73 -2.83 -2.70 -2.65 -2.75 -2.71 -2.71 -2.706
Ohlson O-Score snapshot only -8.639
Net-Net WC snapshot only $-13.70
EVA snapshot only $94367872.50
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB+
Credit Score 74.26 78.76 80.67 82.69 88.03 85.27 88.39 85.02 72.44 59.92 25.92 23.32 20.51 34.22 48.26 47.09 52.20 50.38 46.10 48.03 48.026
Credit Grade snapshot only 11
Credit Trend snapshot only 0.932
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 28
Sector Credit Rank snapshot only 45

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms